Open Access
Open access
volume 206 pages 107258

Cardiovascular disease: Mitochondrial dynamics and mitophagy crosstalk mechanisms with novel programmed cell death and macrophage polarisation

Publication typeJournal Article
Publication date2024-08-01
scimago Q1
wos Q1
SJR2.664
CiteScore18.6
Impact factor10.5
ISSN10436618, 10961186
Abstract
Several cardiovascular illnesses are associated with aberrant activation of cellular pyroptosis, ferroptosis, necroptosis, cuproptosis, disulfidptosis and macrophage polarisation as hallmarks contributing to vascular damage and abnormal cardiac function. Meanwhile, these three novel forms of cellular dysfunction are closely related to mitochondrial homeostasis. Mitochondria are the main organelles that supply energy and maintain cellular homeostasis. Mitochondrial stability is maintained through a series of regulatory pathways, such as mitochondrial fission, mitochondrial fusion and mitophagy. Studies have shown that mitochondrial dysfunction (e.g., impaired mitochondrial dynamics and mitophagy) promotes ROS production, leading to oxidative stress, which induces cellular pyroptosis, ferroptosis, necroptosis, cuproptosis, disulfidptosis and macrophage M1 phenotypic polarisation. Therefore, an in-depth knowledge of the dynamic regulation of mitochondria during cellular pyroptosis, ferroptosis, necroptosis, cuproptosis, disulfidptosis and macrophage polarisation is necessary to understand cardiovascular disease development. This paper systematically summarises the impact of changes in mitochondrial dynamics and mitophagy on regulating novel cellular dysfunctions and macrophage polarisation to promote an in-depth understanding of the pathogenesis of cardiovascular diseases and provide corresponding theoretical references for treating cardiovascular diseases.
Found 
Found 

Top-30

Journals

1
2
3
Frontiers in Cardiovascular Medicine
3 publications, 8.33%
Scientific Reports
2 publications, 5.56%
Free Radical Biology and Medicine
2 publications, 5.56%
Phytomedicine
2 publications, 5.56%
ACS Medicinal Chemistry Letters
1 publication, 2.78%
Journal of Agricultural and Food Chemistry
1 publication, 2.78%
Seminars in Cancer Biology
1 publication, 2.78%
Biomolecules
1 publication, 2.78%
Cell Biochemistry and Function
1 publication, 2.78%
Journal of Pharmacology and Experimental Therapeutics
1 publication, 2.78%
FASEB Journal
1 publication, 2.78%
Clinical and Translational Medicine
1 publication, 2.78%
Redox Biology
1 publication, 2.78%
Molecular Brain
1 publication, 2.78%
ESC heart failure
1 publication, 2.78%
International Journal of Molecular Sciences
1 publication, 2.78%
Handbook of Research on Trends in the Diagnosis and Treatment of Chronic Conditions
1 publication, 2.78%
Research in Veterinary Science
1 publication, 2.78%
Stem Cell Research and Therapy
1 publication, 2.78%
Respiratory Research
1 publication, 2.78%
Frontiers in Cellular and Infection Microbiology
1 publication, 2.78%
Cells
1 publication, 2.78%
Molecular and Cellular Toxicology
1 publication, 2.78%
American Journal of Physiology - Cell Physiology
1 publication, 2.78%
Reviews in Cardiovascular Medicine
1 publication, 2.78%
Journal of Inflammation Research
1 publication, 2.78%
Antioxidants and Redox Signaling
1 publication, 2.78%
Frontiers in Immunology
1 publication, 2.78%
Frontiers in Pharmacology
1 publication, 2.78%
Fitoterapia
1 publication, 2.78%
1
2
3

Publishers

1
2
3
4
5
6
7
8
9
Elsevier
9 publications, 25%
Springer Nature
6 publications, 16.67%
Frontiers Media S.A.
6 publications, 16.67%
Wiley
4 publications, 11.11%
MDPI
3 publications, 8.33%
American Chemical Society (ACS)
2 publications, 5.56%
IGI Global
1 publication, 2.78%
American Physiological Society
1 publication, 2.78%
IMR Press
1 publication, 2.78%
Taylor & Francis
1 publication, 2.78%
Mary Ann Liebert
1 publication, 2.78%
S. Karger AG
1 publication, 2.78%
1
2
3
4
5
6
7
8
9
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
36
Share
Cite this
GOST |
Cite this
GOST Copy
Liu D. et al. Cardiovascular disease: Mitochondrial dynamics and mitophagy crosstalk mechanisms with novel programmed cell death and macrophage polarisation // Pharmacological Research. 2024. Vol. 206. p. 107258.
GOST all authors (up to 50) Copy
Liu D., Qin H., Gao Y., Sun M., Wang M. Cardiovascular disease: Mitochondrial dynamics and mitophagy crosstalk mechanisms with novel programmed cell death and macrophage polarisation // Pharmacological Research. 2024. Vol. 206. p. 107258.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.phrs.2024.107258
UR - https://linkinghub.elsevier.com/retrieve/pii/S1043661824002032
TI - Cardiovascular disease: Mitochondrial dynamics and mitophagy crosstalk mechanisms with novel programmed cell death and macrophage polarisation
T2 - Pharmacological Research
AU - Liu, Dandan
AU - Qin, Hewei
AU - Gao, Yang
AU - Sun, Mengyan
AU - Wang, Mengnan
PY - 2024
DA - 2024/08/01
PB - Elsevier
SP - 107258
VL - 206
PMID - 38909638
SN - 1043-6618
SN - 1096-1186
ER -
BibTex
Cite this
BibTex (up to 50 authors) Copy
@article{2024_Liu,
author = {Dandan Liu and Hewei Qin and Yang Gao and Mengyan Sun and Mengnan Wang},
title = {Cardiovascular disease: Mitochondrial dynamics and mitophagy crosstalk mechanisms with novel programmed cell death and macrophage polarisation},
journal = {Pharmacological Research},
year = {2024},
volume = {206},
publisher = {Elsevier},
month = {aug},
url = {https://linkinghub.elsevier.com/retrieve/pii/S1043661824002032},
pages = {107258},
doi = {10.1016/j.phrs.2024.107258}
}